About General Genomics
General Genomics is a private company based in Oklahoma City, Oklahoma. It has reported $4,047,786 raised in two offerings on Form D since January 2026. Its chief executive is Aronjol Rosenthal.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2021 | Jan 27, 2026 | $1,272,786fully sold | 8 | $159K | Equity, SAFEsRule 506(b) | Form D ↗ |
| May 31, 2024 | Jan 27, 2026 | $2,775,000fully sold | 21 | $132K | Equity, Debt, CONVERTIBLE NOTESRule 506(b) | Form D ↗ |
| Total, two offerings | $4,047,786 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on General Genomics's Form D filed Jan 27, 2026.
AR
Aronjol Rosenthal
CEO and director
CS
Caleb Stuart
Director